Spero Therapeutics Names Regulatory and Corporate Development Leaders; COO to Retire
Spero appointed Amy Rock as chief regulatory and quality officer and Dae Gon Ha as SVP of corporate development. COO Timothy Keutzer will retire effective Dec. 31, 2026.